KMTSKestra Medical Technologies, Ltd.

$28.78+24% 1Y

What is the market doing?

Mixed

No clear lean: nothing decisive, though in an uptrend.

1 good, 2 neutral
TrendUptrendderived · Oct 23, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +21% vs its 200-day average.

Insider conviction−$9.2M (90 days to Oct 22, 2026)SEC EDGAR · Oct 22, 2026

Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).

Short interest5.5% of sharesFINRA · Sep 30, 2026

Moderately shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returnmiddle of the market
vs 200-day avgbetter than 87% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How KMTS is trading

Kestra Medical Technologies, Ltd. is +24% over the past year while the S&P 500 is +16%: 7.7 points ahead of the market.

+24%

1-year return · S&P 500 +16%

vs 200-day average
+21%

vs 200-day average · a clear uptrend

RSI (14)
52

RSI (14) · neutral

Below its 52-week high
2.1%

Below its 52-week high

Mar 6, 2025$14.46 – $29.40 · dashed line: 200-day averageOct 23, 2026
Details›
Last close2026-10-23
$28.78
1 monthS&P 500 −0.94%
+12%
1 yearS&P 500 +16%
+24%
vs 50-day average$26.51
+8.6%
52-week high
$29.40
52-week low
$17.87
Annualised volatility
66%
Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
$4.7M

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

Where the price stands

Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.

What it has returned

With dividends, year by year, month by month, and by calendar month on average.